Please note that the contents in this webpage are current as of the date of the announcement and the information including but not limited to the product availability, specification, prices, contacts, are subject to change without prior notice.
- Nov 7, 2025
- Fujifilm Launches Joint Research with National Cancer Center to Advance Innovative Cancer Treatments Technology
- Sep 25, 2025
- FUJIFILM Biotechnologies Celebrates the Grand Opening of its Commercial-Scale Cell Culture Manufacturing Site in North Carolina
- Sep 19, 2025
- FUJIFILM Biotechnologies Expands Strategic Partnership with argenx to Include U.S. Manufacturing Operations
- Jun 2, 2025
- Fujifilm Rebrands Life Sciences Companies to Strengthen Position as Strategic Partners for Life, Offering End-to-End Solutions
- May 19, 2025
- Fujifilm Validates Cancer Cell-Targeting Potential of Peptide Oligonucleotide Conjugates with Novel Cyclic Peptides
- Apr 22, 2025
- FUJIFILM Diosynth Biotechnologies and Regeneron Sign a 10-year U.S. Manufacturing Agreement Valued at Over $3 Billion
- Nov 5, 2024
- FUJIFILM Diosynth Biotechnologies Launches First Phase of Global CDMO Ecosystem Expansion
- May 15, 2024
- FUJIFILM Wako Pure Chemical Corporation Installs New Equipment to Triple Production Capacity of GMP-Compliant Raw Materials for Pharmaceutical Manufacturing (FUJIFILM Wako Pure Chemical)
- Apr 12, 2024
- Fujifilm to Invest Additional $1.2 Billion to Expand its Large-Scale Cell Culture CDMO Business in North Carolina
- Apr 1, 2024
- Fujifilm Launches "SYNAPSE Creative Space" Service in Japan
- Feb 29, 2024
- FUJIFILM Diosynth Biotechnologies Announces Renewable Energy PPA with Better Energy for Denmark Manufacturing Site
- Dec 5, 2023
- Fujifilm to Invest USD 200 Million to Expand Cell Therapy Development and Manufacturing Capabilities
- Nov 8, 2023
- FUJIFILM Diosynth Biotechnologies Announces First Tenant for New Manufacturing Facility
- Jun 6, 2023
- Fujifilm to Enhance Commercial Presence in Asia for Biologics and Advanced Therapies Contract Services
- Mar 31, 2023
- Transfer of FUJIFILM Healthcare Systems’ electronic medical record and medical-receipt systems related business to PHC Holdings’ subsidiary
- Dec 20, 2022
- Fujifilm Announces Asset Purchase Agreement with Inspirata, Inc. to acquire the company’s Digital Pathology Business
- Dec 14, 2022
- Fujifilm Invests in PhenoVista Biosciences from its Life Sciences Corporate Venture Capital Fund